Inventor · disambiguated record
Eric Legangneux
Also filed as: LEGANGNEUX ERIC
2 granted patents·19 pending applications·21 citations·filing 2009–2024
60Inventor score
Top patents by PatentIndex Score
21 records- 0184US2024270688A1Identifying patient response to s1p receptor modulator administrationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0280US8492441B2Dosage regimen of an S1P receptor agonistLEGANGNEUX ERIC·Filed 2009·Granted Jul 23, 2013·19 cites·16 claims
- 0379US11944602B2Treatment of autoimmune disease in a patient receiving additionally a beta-blockerNOVARTIS AG·Filed 2021·Granted Apr 2, 2024·2 cites·43 claims
- 0471US2025041266A1S1p modulator immediate release dosage regimenNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0567US2021147354A1Identifying patient response to s1p receptor modulator administrationNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0661US2019135744A1Identifying patient response to s1p receptor modulator administrationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0757US2017320820A1Identifying patient response to s1p receptor modulator administrationNOVARTIS AG·Filed 2017·Application pending·0 cites
- 0856US2016046573A1Identifying patient response to s1p receptor modulator administrationBORELL HUBERT·Filed 2013·Application pending·0 cites
- 0952US2022016076A1Sip modulator immediate release dosage regimenNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1052US2020383947A1Treatment of autoimmune disease in a patient receiving additionally a beta-blockerNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1149US2019038599A1Treatment of autoimmune disease in a patient receiving additionally a beta-blockerNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1249US2018161290A1Dosage Regimen of Diaryl Sulfide DerivativesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1348US2014336265A1Dosage Regimen of Diaryl Sulfide DerivativesGERGELY PETER·Filed 2014·Application pending·0 cites
- 1446US2019054065A1Sip modulator immediate release dosage regimenNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1542US2018042895A1Treatment of autoimmune disease in a patient receiving additionally a beta-blockerNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1641US2017119702A1Dosage Regimen of Diaryl Sulfide DerivativesGERGELY PETER·Filed 2016·Application pending·0 cites
- 1740US2013210924A1Dosage Regimen of Diaryl Sulfide DerivativesGERGELY PETER·Filed 2011·Application pending·0 cites
- 1839US2020306222A1Dosing Regimen of SiponimodNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1939US2013281712A1Dosage Regimen of an S1P Receptor AgonistLEGANGNEUX ERIC·Filed 2013·Application pending·0 cites
- 2034US2020316021A1Dosing Regimen of SiponimodNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2133US2017027907A1Sip modulator immediate release dosage regimenLEGANGNEUX ERIC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eric Legangneux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →